Tissue‐specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral‐mediated transfer of the wild‐type p53 gene
G W Xu, Z T Sun, K Forrester, X W Wang, J Coursen, C C Harris – 1 November 1996 – Selective expression of cytotoxic gene products in tumor cells is one of the goals of gene therapy for treating cancer. We are developing such a strategy for the treatment of human hepatocellular carcinoma (HCC) by linking the wild‐type p53 (WT‐p53) gene with HCC‐associated transcriptional control elements (TCE) to achieve selective growth inhibition of retrovirally transduced HCC cells.